Karim Nagi

8PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersEnergy generation, conversion and storage (excl. chemical and electrical)Cheminformatics and quantitative structure-activity relationshipsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 31, 2025
Global Prevalence and Cancer Risk of Epstein-Barr Virus and Human Papillomavirus Coinfection in Breast Cancer: A Systematic Review and Meta-Analysis.

Abdelrahman A Karen, Albara S Elkhalaf, Omar Tluli

|Oct 04, 2024
USP20 deletion promotes eccentric cardiac remodeling in response to pressure overload and increases mortality.

Pierre-Yves Jean-Charles, Bipradas Roy, Samuel Mon-Wei Yu

|Apr 19, 2023
How can we improve the measurement of receptor signaling bias?

Karim Nagi

|Oct 18, 2021
Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation.

Ahmed Mansour, Karim Nagi, Paul Dallaire

|Aug 07, 2021
Copresence of High-Risk Human Papillomaviruses and Epstein-Barr Virus in Colorectal Cancer: A Tissue Microarray and Molecular Study from Lebanon.

Karim Nagi, Ishita Gupta, Nawaf Jurdi

|Jun 11, 2021
High-risk human papillomaviruses and Epstein-Barr virus in breast cancer in Lebanese women and their association with tumor grade: a molecular and tissue microarray study.

Karim Nagi, Ishita Gupta, Nawaf Jurdi

Pageof 2

Frequent Collaborators

3 joint publications

Michel Bouvier

2 joint publications

Emma Van Der Westhuizen

1 joint publications

Ala-Eddin Al-Moustafa

1 joint publications

Semir Vranic